LFB
France - ParisBiotechnology
Focus: LFB is a mid-cap biotech specializing in plasma-derived drug products for rare coagulation and bleeding disorders, headquartered in Paris with 1,001-5,000 employees.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Employees
1001-5000
Open Jobs
169+69 this month
Hot — 83 jobs added in 30d
Net +69 (83 new, 14 removed). Aggressive expansion phase.
Should You Work at LFB?
AI assessmentBest suited for manufacturing, QA, and supply chain professionals seeking stable roles in a plasma-derived biotech, but limited for those seeking R&D growth or commercial leadership opportunities.
Why Work Here
- Rare disease focus offers deep clinical expertise in hemophilia and bleeding disorders with multiple Phase 2-4 programs advancing simultaneously
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Blood samples for PK
Fibrinogen Deficiency in Complex Cardiac SurgeryClinical Trials (1)
NCT07425600Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass
N/AHelp build intelligence for LFB
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.